XRCC1 shows potential as a prognostic and immunological pan-cancer biomarker

A new research paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science) Volume 16, Issue 1, entitled, “XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis.”

WHO Endorses Polypills; SAVR Valve Recall; Bronny James Recovering

The WHO Model List of Essential Medicines added three polypills for the prevention of atherosclerotic cardiovascular disease. Low-dose aspirin failed to reduce ischemic stroke among

August 2, 2023

Biodegradable diagnostic tests offer sustainable solution to plastic pollution

The global plastic pollution crisis and the fallout from the COVID-19 pandemic – where billions of single-use diagnostic tests were discarded – is prompting businesses

August 31, 2024

Amyloid immunotherapy for early Alzheimer’s: Promising but fraught with challenges

Researchers highlighted the complexities of using amyloid immunotherapy for early Alzheimer’s disease, discussing its clinical benefits, challenges, and broader health implications. Despite some positive results,

August 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.